These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 9287388)

  • 21. Radiographic progression in early rheumatoid arthritis: a 12-month randomized controlled study comparing the combination of cyclosporin and methotrexate with methotrexate alone.
    Marchesoni A; Battafarano N; Arreghini M; Panni B; Gallazzi M; Tosi S
    Rheumatology (Oxford); 2003 Dec; 42(12):1545-9. PubMed ID: 12810924
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Does Concomitant Methotrexate with Adalimumab Influence Treatment Outcomes in Patients with Psoriatic Arthritis? Data from a Large Observational Study.
    Behrens F; Koehm M; Arndt U; Wittig BM; Greger G; Thaçi D; Scharbatke E; Tony HP; Burkhardt H
    J Rheumatol; 2016 Mar; 43(3):632-9. PubMed ID: 26669916
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Should Methotrexate Have Any Place in the Treatment of Psoriatic Arthritis?
    Ye W; Coates LC
    Rheum Dis Clin North Am; 2019 Aug; 45(3):325-339. PubMed ID: 31277747
    [TBL] [Abstract][Full Text] [Related]  

  • 24. US consensus guidelines for the use of cyclosporin A in rheumatoid arthritis.
    Cush JJ; Tugwell P; Weinblatt M; Yocum D
    J Rheumatol; 1999 May; 26(5):1176-86. PubMed ID: 10332987
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Value of combining biologics with methotrexate for treatment of psoriatic arthritis-questions remain].
    Dauth S; Köhm M; Rossmanith T; Herrmann E; Lehn A; Burkhardt H; Behrens F
    Z Rheumatol; 2018 Nov; 77(9):808-814. PubMed ID: 30203153
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT).
    Antoni CE; Kavanaugh A; Kirkham B; Tutuncu Z; Burmester GR; Schneider U; Furst DE; Molitor J; Keystone E; Gladman D; Manger B; Wassenberg S; Weier R; Wallace DJ; Weisman MH; Kalden JR; Smolen J
    Arthritis Rheum; 2005 Apr; 52(4):1227-36. PubMed ID: 15818699
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Psoriatic arthritis: treatment strategies using anti-inflammatory drugs and classical DMARDs.
    Lubrano E; Scarpa R
    Reumatismo; 2012 Jun; 64(2):107-12. PubMed ID: 22690387
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cyclosporine A in juvenile idiopathic arthritis. Results of the PRCSG/PRINTO phase IV post marketing surveillance study.
    Ruperto N; Ravelli A; Castell E; Gerloni V; Haefner R; Malattia C; Kanakoudi-Tsakalidou F; Nielsen S; Bohnsack J; Gibbas D; Rennebohm R; Voygioyka O; Balogh Z; Lepore L; Macejkova E; Wulffraat N; Oliveira S; Russo R; Buoncompagni A; Hilário MO; Alpigiani MG; Passo M; Lovell DJ; Merino R; Martini A; Giannini EH; ;
    Clin Exp Rheumatol; 2006; 24(5):599-605. PubMed ID: 17181934
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methotrexate in psoriatic arthritis.
    Cutolo M; Seriolo B; Pizzorni C; Craviotto C; Sulli A
    Clin Exp Rheumatol; 2002; 20(6 Suppl 28):S76-80. PubMed ID: 12463453
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Step-down approach using either cyclosporin A or methotrexate as maintenance therapy in early rheumatoid arthritis.
    Marchesoni A; Battafarano N; Arreghini M; Pellerito R; Cagnoli M; Prudente P; Cerase A; Priolo F; Tosi S
    Arthritis Rheum; 2002 Feb; 47(1):59-66. PubMed ID: 11932879
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of cyclosporine A as monotherapy in patients with psoriatic arthritis: a subgroup analysis of the SYNERGY Study.
    Colombo D; Chimenti S; Grossi PA; Marchesoni A; Foti R; Calzavara-Pinton P; Zagni E; Ori A; Bellia G;
    G Ital Dermatol Venereol; 2017 Jun; 152(3):297-301. PubMed ID: 26837484
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The relationship between serum-soluble interleukin-2 receptor and radiological evolution in psoriatic arthritis patients treated with cyclosporin-A.
    Macchioni P; Boiardi L; Cremonesi T; Battistel B; Casadei-Maldini M; Beltrandi E; Mancini R; Salvarani C
    Rheumatol Int; 1998; 18(1):27-33. PubMed ID: 9672996
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness and retention rates of methotrexate in psoriatic arthritis in comparison with methotrexate-treated patients with rheumatoid arthritis.
    Lie E; van der Heijde D; Uhlig T; Heiberg MS; Koldingsnes W; Rødevand E; Kaufmann C; Mikkelsen K; Kvien TK
    Ann Rheum Dis; 2010 Apr; 69(4):671-6. PubMed ID: 19740904
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disease-modifying Antirheumatic Drugs (DMARD) and Combination Therapy of Conventional DMARD in Patients with Spondyloarthritis and Psoriatic Arthritis with Axial Involvement.
    Simone D; Nowik M; Gremese E; Ferraccioli GF
    J Rheumatol Suppl; 2015 Nov; 93():65-9. PubMed ID: 26523061
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of Etanercept Monotherapy and Combination Therapy with Methotrexate in Psoriatic Arthritis: Results from 2 Clinical Trials.
    Combe B; Behrens F; McHugh N; Brock F; Kerkmann U; Kola B; Gallo G
    J Rheumatol; 2016 Jun; 43(6):1063-7. PubMed ID: 27134249
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyclosporine in psoriatic arthropathy.
    Soriano A; Pipitone N; Salvarani C
    Clin Exp Rheumatol; 2015; 33(5 Suppl 93):S101-3. PubMed ID: 26470797
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reversion of resistance to immunosuppressive agents in three patients with psoriatic arthritis by cyclosporine A: modulation of P-glycoprotein function.
    Diamanti AP; Rosado M; Germano V; Scarsella M; Giorda E; Podestà E; D'Amelio R; Carsetti R; Laganà B
    Clin Immunol; 2011 Jan; 138(1):9-13. PubMed ID: 21062675
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnosing and treating psoriatic arthritis: an update.
    Boehncke WH; Qureshi A; Merola JF; Thaçi D; Krueger GG; Walsh J; Kim N; Gottlieb AB
    Br J Dermatol; 2014 Apr; 170(4):772-86. PubMed ID: 24266754
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Minimal Disease Activity and Remission in Psoriatic Arthritis Patients Treated with Anti-TNF-α Drugs.
    Perrotta FM; Marchesoni A; Lubrano E
    J Rheumatol; 2016 Feb; 43(2):350-5. PubMed ID: 26669925
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of biologic agents and other disease-modifying antirheumatic drugs on cardiovascular outcomes in psoriasis and psoriatic arthritis: a systematic review.
    Armstrong AW; Brezinski EA; Follansbee MR; Armstrong EJ
    Curr Pharm Des; 2014; 20(4):500-12. PubMed ID: 23565631
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.